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Abstract
Objective To form and assess a set of diagnostic ultrasound
criteria to select malignant nodules for fine-needle aspiration
(FNA) cytology and reduce number of FNA biopsies.
Methods In this prospective observational service evalua-
tion study, 171 thyroid nodules that underwent FNA cytol-
ogy were independently scored by two observers for
established nodular sonographic characteristics for malig-
nancy. The final diagnosis was confirmed by surgery or a 6-
month follow-up in nodules with benign cytology.
Results Logistic regression analysis and receiver operating
characteristic curve analysis results indicate good and com-
parable predictive powers of certain ultrasound characteris-
tics in predicting malignancy. The highest sensitivity in
detecting malignancy was achieved when taking together the
information of marked hypoechogenicity, microcalcification
and mixed central/peripheral or central Doppler colour flow
pattern. A sensitivity of 100 % and a specificity of 76 % were
obtained in detecting malignant nodules using this criteria.
Conclusions Our study proposes a set of ultrasound and
colour Doppler criteria to safely select malignant thyroid
nodules for FNA cytology.
Main messages:
• There is a need to safely select malignant nodules for FNA
cytology and reduce unnecessary FNA
• Some ultrasound features are specific but none are
independently/fully predictive of malignancy
• We have prospectively tested a set of ultrasound criteria
for selecting nodules for FNA cytology
• Our ultrasound criteria detected malignant nodules with a
100 % sensitivity and 76 % specificity
• A high sensitivity is clinically desirable as it selects many,
if not all, malignant nodules for FNA
Keywords Thyroid . Nodule . Malignancy . Ultrasound .
Doppler
Introduction
In the evaluation of thyroid nodules, high-resolution ultrasound
is being increasingly used to detect malignancy and guide fine-
needle aspiration (FNA) for cytological analysis. There have
been consensus statements and guidelines from professional
bodies for the diagnostic role of ultrasound inmanaging thyroid
nodular disease [1–6] as there is a need to safely select malig-
nant nodules for FNA cytology and reduce unnecessary FNA
or biopsies. Ultrasound features are specific for malignan-
cy and include irregular contours, microcalcification and
intranodular colour Doppler flow pattern but none of
them are independently and fully predictive of malig-
nancy [1, 2, 6–9]. A prospective study by Dominguez et
al. [9] has indicated that the simultaneous presence or
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absence of these specific ultrasound and colour Doppler
characteristics can change the pre-test probability for
malignancy.
Currently in our institution, we offer FNA cytology analysis
routinely in the evaluation of thyroid nodules but recognise the
need to be discerning in selecting malignant nodules for FNA
cytology and hence reduce unnecessary FNA biopsies [6, 10].
We therefore aim to, in our prospective service analysis
study, form and test the diagnostic performance of a set
of ultrasound and colour Doppler criteria to safely select




Ethical approval was obtained from our institution’s re-
search development unit. Written informed consent was
waived by the institutional review board.
Patient selection
Our service evaluation study included a total of 215 patients
seen at our head and neck ultrasound clinic from January 2006
Table 1 Royal College of Pathologists (RCPath) modified British Thyroid association nomenclature and comparison to the Bethesda system for
reporting thyroid cytopathology: recommended diagnostic categories (adapted from [11])
RCPath category Bethesda system
Thy1 Non-diagnostic Virtually acellular specimen
Other (obscuring blood, clotting artefact, etc.)
Cyst fluid only
Thy2 Benign non-neoplastic Consistent with a benign follicular nodule
(includes adenomatoid nodule, colloid nodule, etc.)
Consistent with lymphocytic (Hashimoto) thyroiditis
Consistent with granulomatous (subacute) thyroiditis
Thy3 Neoplasm possible—atypia/non-diagnostic (Thy 3a) Atypia of undetermined significance or follicular lesion
of undetermined significance
Neoplasm possible, suggesting follicular neoplasm (Thy 3f) Follicular neoplasm or suspicious for a follicular neoplasm
Thy4 Suspicious of malignancy Suspicious (but not diagnostic) of papillary, medullary or
anaplastic carcinoma, or lymphoma
Thy5 Diagnostic of malignancy Unequivocal features of papillary, medullary or anaplastic
carcinoma, lymphoma or metastatic tumour or other
Table 2 Logistic regression analysis for Observer 1’s category scores. Observer 2’s category scores are almost identical
Outcome Category Malignant n (%) Odds ratio (95 % CI) p value
Echogenicity Hyperechoic/isoechoic 5/68 (7 %) 1
Hypoechoic 4/42 (10 %) 1.33 (0.33, 5.24)
Markedly hypoechoic 8/13 (62 %) 20.2 (4.77, 85.2)
Cyst 2/48 (4 %) 0.55 (0.10, 2.95) <0.001
Contour Well defined 11/157 (7 %) 1
Borderline/ill-defined 8/14 (57 %) 17.7 (5.21, 60.1) <0.001
Colour flow No flow/peripheral flow 0/78 (0 %)
Peripheral > central flow 5/43 (12 %)
Central flow ≥ peripheral flow 14/50 (28 %) a <0.001
Colour flow (grouped) No flow or peripheral > central flow 5/121 (7 %) 1
Central flow ≥ peripheral flow 14/50 (46 %) 9.02 (3.04, 26.8) <0.001
Calcification No 13/157 (8 %)
Coarse 1/9 (11 %)
Microcalcification 5/5 (100 %) a <0.001
Calcification (grouped) No 13/157 (8 %) 1
Coarse or microcalcification 6/14 (43 %) 6.63 (2.61, 16.8) 0.002
a Unable to calculate odds ratios or perform logistic regression due to all values in some categories having said outcome. Analysis using Fisher’s
exact test
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to July 2010. They were referred for ultrasound of the thyroid
gland and FNA cytology by general practitioners and hospital
clinicians. The clinical indications included lump in the neck
and assessment of goitre.
Ultrasound and FNA assessment
All the patients had ultrasound examination and FNA cy-
tology performed in the clinic by a consultant radiologist
with 4 years’ experience in thyroid ultrasound at the time of
the study, in accordance with the requirement of our existing
service provision. Ultrasound with colour Doppler was
performed with an HDI 5000 scanner (Advanced Technol-
ogy Laboratories, Bothell, WA) using a 12-MHz linear
probe from 2006 to 2007 and an Acuson Antares scanner
(Siemens Medical Solutions, USA) with a 13.5-MHz linear
probe from 2007 to 2008. Colour Doppler ultrasonography
was used for the assessment of nodule vascularity for
all nodules on longitudinal and transverse planes. The
amplifier gain was individually established in each stud-
y; the amplifier gain was raised until random colour
noise appeared and then slightly lowered to situate it
at a level immediately under the point of appearance of
random colour noise.
In line with our existing service provision, all patients
with nodules were selected by the radiologist for FNA
cytology analysis. All solitary nodules were selected for
FNA cytology regardless of their sonographic and colour
Doppler features. When a multinodular thyroid gland is
encountered, the largest nodule was included in the study
unless an atypical nodule with ultrasound features specific
for malignancy was encountered [2, 6]. Recognised features
suspicious for malignancy used include: microcalcification,
ill—defined contours, marked hypogenicity and presence of
internal or mixed vascularity [1, 2]. FNA was performed
using a 21-G needle following verbal consent and smeared
using an air-dried and fixed slide. FNA of a mixed solid–
cystic nodule was directed at the solid component. If abnor-
mal regional lymphadenopathy was present, FNA was also
performed at the abnormal lymph nodes.
Table 3 The results of the mul-
tivariable analysis based on Ob-
server 1’s category scores
analysis indicated some evi-
dence that all four factors were
significantly associated with the
outcome (Model 1). However,
the result for contour was not
quite statistically significant.
When only strictly significant
variables were considered
(Model 2), the results suggested
that echogenicity, colour flow
and calcification were still all
significantly associated with the
outcome. Observer 2’s category
scores are almost identical
Outcome Category Odds ratio (95 % CI) p value
Model 1
Echogenicity Hyperechoic/isoechoic 1
Hypoechoic 0.55 (0.08, 3.56)
Markedly hypoechoic 6.81 (1.11, 41.9)
Cyst 0.48 (0.06, 3.81) 0.04
Contour Well defined 1
Borderline/ill-defined 8.11 (0.72, 91.2) 0.09
Colour flow No flow or peripheral > central flow 1
Central flow ≥ peripheral flow 26.0 (4.07, 166) 0.001
Calcification No calcification 1
Coarse calcification or microcalcification 5.83 (1.18, 28.9) 0.03
Model 2
Echogenicity Hyperechoic/isoechoic 1
Hypoechoic 0.84 (0.16, 4.33)
Markedly hypoechoic 9.69 (1.81, 51.9)
Cyst 0.42 (0.05, 3.67) 0.01
Colour flow No flow or peripheral > central flow 1
Central flow ≥ peripheral flow 25.1 (4.05, 156) 0.001
Calcification No 1
Coarse calcification or Microcalcification 12.1 (2.66, 54.9) 0.001
Fig. 1 Receiver operating characteristic (ROC) curve for observer 1 shows
high area-under-the-curve (AUC) values, indicating good diagnostic perfor-
mance in predicting the outcome. The ROC curve for observer 2 is similar
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Ultrasound and colour Doppler scoring
For the purpose of the study, the sonographic and colour
Doppler features of the nodule that was selected for FNA
cytology analysis were categorised for echogenicity, con-
tours, nodular colour Doppler flow characteristics and the
presence of calcification, all of which are regarded as im-
portant ultrasound signs associated with malignancy [1, 2].
The echogenicity of the nodule was compared with the
surrounding parenchyma and was classified as markedly
hypoechoic, hypoechoic, isoechoic/hyperechoic or cystic.
If a cystic nodule is encountered, it is assessed for the other
characteristics as with the solid nodules, such as contour,
internal vascularity and calcification in its soft tissue com-
ponent. Markedly hypoechoic was defined as lower
echogenicity than the adjacent strap muscles. Contours were
scored as well defined (crisp) margins or ill–defined
(blurred, infiltrative) margins. The presence of calcification
was scored as coarse calcification or microcalcifications, the
latter being defined as tiny (less than 2 mm) linear
hyperechoic foci with or without acoustic shadow. Nodular
colour Doppler flow pattern was categorised as no flow,
peripheral flow only, mixed flow (peripheral more than
central), mixed flow (central more than peripheral) and
central flow only. To evaluate for interobserver agreement,
the nodules were also scanned and scored independently in
the clinic by a second observer, a sonographer with 3 years’
experience in thyroid ultrasound.
Cytological assessment and final diagnosis
As per our existing service provision, the slides were exam-
ined by cytologists experienced in thyroid cytology and
graded in line with the British Thyroid Association [3] and
Royal College of Pathologists [11] guidelines (Table 1). All
nodules with a Thy2 cytology diagnosis denote benign non-
neoplastic lesions, typically colloid nodules, thyroiditis and
hyperplastic nodules [3, 11]. Occasional hyperplastic
nodules show a microfollicular pattern with minimal colloid
precluding a Thy2 diagnosis as it is not possible to differ-
entiate from a neoplastic or potential malignant lesion. The-
se nodules are classified as Thy3 [3, 4]. All nodules with a
potential malignant cytology grading (Thy3, Thy4 and
Thy5), were referred for surgery, with histological diagnosis
obtained in all these cases.
The final diagnosis of malignant nodules is based on sur-
gery with histological diagnosis. The diagnosis of benign non-
neoplastic nodules was based on Thy 2 cytology and they were
also followed-up after 6 months to ensure stability; any nodule
with a 20 % increase in diameter with minimum increase in
two or more dimensions of 2 mm would be subjected to a
further FNA cytological analysis to establish benignity [4].
Surgery with histological confirmation was available for some
benign nodules where surgery was performed for cosmetic or
compressive symptoms or nodules with Thy 3 cytology.
Statistical analyses
Logistic regression was used to predict the probability of a
malignant nodule for each patient based on the four ultra-
sound characteristics (echogenicity, contour, colour flow,
presence of calcification). Receiver operating characteristic
(ROC) curve analysis was used to examine the performance
of these predicted values in determining a malignant result.
ROC curve analysis was performed using the Stata software
(version 9.2; StataCorp LP, Texas, USA).
Table 4 A summary of the per-
formance of two ROC curve cut-
offs that could be best used to
predict the final diagnosis. One
cut-off is chosen to give the best
sensitivity and a second to give
the optimum combination of
sensitivity and specificity
(overall accuracy)
Method Statistic Estimate (95 % CI)
Regression results 1
(best sensitivity)
Sensitivity 1.00 (0.82, 1.00)
Specificity 0.75 (0.67, 0.82)
Positive predictive value 0.33 (0.21, 0.47)
Negative predictive value 1.00 (0.96, 1.00)





Sensitivity 0.95 (0.74, 1.00)
Specificity 0.81 (0.74, 0.87)
Positive predictive value 0.38 (0.25, 0.54)
Negative predictive value 0.99 (0.96, 1.00)
Overall accuracy 0.82 (0.76, 0.88)
Table 5 Proposed set of ultrasound criteria for selecting thyroid nod-
ules for FNA cytology analysis. Nodules are selected if any of these
features are seen on ultrasound
Thyroid nodular ultrasound features for selecting nodules for FNA
Central or mixed colour Doppler flow pattern
Markedly hypoechoic
Microcalcification
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Results
Forty-four patients were excluded from the study as they were
lost to follow–up scans to ensure benignity or the histology
reports were unavailable (surgery at another centre or surgery
refused). Of the 171 cases that were included in the study, there
were 34male and 141 female patients, and the median age was
48 years (range 18–88 years). One hundred and fifty-three
were benign (140 were non-neoplastic and 13 were benign
neoplasms [10 follicular adenoma, 3 hurthle cell neoplasm on
histology]) and 18 were malignant (10 papillary carcinoma, 5
follicular carcinoma, 1 hurtle cell microcarcinoma, 1medullary
carcinoma and 1 lymphoma on histology). All the malignant
nodules had cytology scores of Thy 3, Thy 4 or Thy 5, apart
from one case of follicular carcinomawith a Thy1 score. Of the
140 benign non-neoplastic nodules, 10 cases had an indeter-
minate Thy3 cytology grade and therefore underwent surgery
with histological confirmation of absence of cancer. The
remaining 130 cases had Thy2 cytology grade, 12 of which
had surgery and histological confirmation of benignity.
The thyroid nodules vary in size, with diameters
ranging from 0.6 cm to 7.5 cm. There is no significant
difference in size between the benign nodules (mean
2.7 cm, SD 1.7 cm) and the malignant nodules (mean
2.8 cm, SD 1.1 cm) (unpaired t-test, p=0.68). There
was also no significant difference between benign and
malignant nodules in being palpable or not palpable
(chi-squared test p=0.15) or in being solitary or occur-
ring in a multinodular gland (chi-squared test p=0.22).
Logistic regression analysis results for both observers
(Table 2) suggest that all four ultrasound characteristics
(echogenicity, contour, colour flow, presence of calcification)
are significantly associated with the final diagnosis. Marked
hypoechogenicity, ill defined contour, mixed central/peripheral
flow or central flow and calcification are featuresmost likely to
be associated with malignant nodules. The results of the mul-
tivariable analysis for both observers (Table 3) indicate that
echogenicity, calcification and colour flow are still all signifi-
cantly associated with the final diagnosis. However, the result
for contour was not quite statistically significant. All the five
nodules demonstrating microcalcification were malignant.
The area under the ROC curves (Fig. 1) for both ob-
servers are of high value indicating good and comparable
predictive powers of the logistic regression analysis in
predicting the final diagnosis. The area under the curve
(AUC) value for observer 1 and 2 is identical at 0.94 with
95 % CI of 0.90–0.98. Two different cut-offs were chosen at
the ROC curves, one to give the best sensitivity, and a
second to give the optimum combination of sensitivity and
specificity (overall accuracy). The results are identical for
both observers and are shown in Table 4.
Based on the results of the logistic regression and ROC
curve analysis and the fact that all cases demonstrating
microcalcification were malignant, we propose a set of
ultrasound selection criteria for detecting malignant nodules
and selecting them for FNA cytology (Table 5). The diag-
nostic performance of this selection criteria is listed in
Table 6.
Discussion
In the investigation of thyroid nodules, there is a need to
safely select nodules for FNA cytological analysis to max-
imise benefits and minimise cost, given the high incidence
of thyroid nodules [6, 10]. Evidence is gathering that the
malignant potential of thyroid nodules may not be strongly
associated with nodule size or palpability or whether they
are solitary or occur in a multinodular gland [1, 2, 5–8, 10].
Clinical risk factors such as a history of head and neck
Table 6 Diagnostic perfor-
mance of the two observers in
detecting malignant thyroid
nodules using ultrasound criteria
outlined in Table 4. This illus-
trates a safe approach where all
malignant nodules are selected
for FNA cytology analysis
Observer 1 (95 % CI) Observer 2 (95 % CI)
Sensitivity 1.00 (0.78, 1.00) 1.00 (0.78, 1.00)
Specificity 0.76 (0.69, 0.83) 0.72 (0.64, 0.79)
Positive predictive value 0.33 (0.21, 0.48) 0.30 (0.19, 0.43)
Negative predictive value 1.00 (0.96, 1.00) 1.00 (0.96, 1.00)
Fig. 2 Ultrasound images of
the thyroid gland showing (a)
markedly hypoechoic nodule
(between callipers) with ill-
defined irregular contour and
(b) mixed flow pattern with
central flow on colour Doppler.
Surgical excision and histology
revealed a papillary thyroid
carcinoma
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irradiation, thyroid cancer, a family history of thyroid cancer
or familial adenomatous polyposis, rapid growth, vocal cord
paralysis and regional lymphadenopathy [1, 6, 8] are un-
common. There is thus increasing reliance on ultrasound
and colour Doppler, by virtue of certain specific character-
istics for detecting malignancy, to select nodules for FNA or
biopsy [2]. It has also been recommended that in a
multinodular gland FNA should be targeted by suspicious
ultrasound features rather than by a nodule being clinically
dominant [2, 5, 6].
In our service evaluation study, we have tested a set of
ultrasound and colour Doppler selection criteria for detecting
malignant nodules and selecting them for FNA cytology
(Table 5). The characteristics of calcification, mixed colour
flow pattern and markedly hypoechoic echo texture (Fig. 2) all
have high odds ratios on the logistic regression (multivariable)
analysis. In particular, microcalcification is the most specific
sign, with all the five nodules demonstrating it being malig-
nant. A sensitivity of 100 % (Table 6) is obtained making it a
safe approach with all malignant nodules ‘earmarked’ and
selected for FNA cytology. Even though this selection
criterion has a lower specificity of 76 %, we have demonstrat-
ed that it can reduce substantially the number of required FNA
biopsies. In our series of 171 patients, 117 out of the 153
benign nodules (Fig. 3) would not have required FNA cytol-
ogy analysis to establish benignity if the selection criterion
(Table 5) was applied in the first instance, with consequent
benefit to both patient and service provision and reduction in
cost.
The lower specificity is due to 36 false-positive cases. The
most common nodular characteristic leading to false positive
diagnosis is the presence of central or mixed colour flow
pattern on Doppler ultrasound seen in 32 out of 36 false-
positive cases (Fig. 4). But it is this characteristic that is the
only abnormal characteristic in 6 of the 18 malignant nodules.
The high sensitivity and lower positive predictive value of
colour Doppler pattern in detecting malignancy is well docu-
mented in other studies [7, 12, 13]. A less common cause of
false-positive result is marked hypoechogenicity (five cases).
It is, however, the only abnormal feature in two malignant
nodules. Seven out of eight cases of coarse calcification were
false-positive for malignancy and in the one case of malignan-
cy with coarse calcification, florid intranodular colour flow
was also seen. By contrast, all five cases of microcalcification
were malignant nodules, making it the most specific sign for
malignancy. This sign is, however, also associated with either
marked hypoechogenicity or marked intranodular colour flow
in four out of five cases. Of a particular note is one case of
histologically proven follicular carcinoma which had two non–
diagnostic Thy1 cytology results preoperatively. This nodule
was markedly hypoechoic and had marked central vascularity
on ultrasound. Hence, in the case of a nodule where cytology is
repeatedly non-diagnostic, ultrasound with colour Doppler can
be valuable in helping the surgeon decide on surgery.
With regards to prospective studies investigating the use
of ultrasound with colour Doppler [7, 9, 14, 15], our study
is, to our knowledge, the larger of two prospective studies
[14] testing the diagnostic performance of a set of ultra-
sound and colour Doppler criteria in detecting malignancy
in palpable and non-palpable thyroid nodules, where the
Fig. 3 Ultrasound of the thyroid gland showing a benign colloid
nodule which has typical ultrasound features of a non-neoplastic nod-
ule. This nodule has a well-defined contour, an isoechoic/hyperechoic
echo texture and demonstrates peripheral flow on colour Doppler
Fig. 4 False-positive cases for
malignancy. Ultrasound images
of (a) a solid—cystic follicular
adenoma and (b) a benign
hyperplastic nodule. The
nodules demonstrated mixed
(central and peripheral) colour
flow pattern on colour Doppler
and selected for FNA using our
criteria in Table 5
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final diagnosis is established by histology for all malignant
and indeterminate nodules and cytology with follow-up for
all nodules with benign cytology. In a smaller study of 66
patients (78 thyroid nodules), Yunus et al. [14] demonstrated
a slightly lower sensitivity and specificity of 93.8 % and
66 % respectively compared with ours in detecting malig-
nancy for a set of selection criteria that are similar to ours
but also included a taller than wide shape of the nodule and
nodular irregularity/microlobulations. Their study, however,
included only solid nodules (cystic nodules excluded).
In interpreting the results, it is important to note the limi-
tations of our prospective study. Our study is part of a service
evaluation with the aim of informing the evidence around
rationalising selection for FNA. Many patients in our hospital
catchment area are managed in primary care by general prac-
titioners who refer mainly more complex cases to our clinic. In
addition, there is selection bias with many nodules, with
benign cytology being excluded from the study, having not
being followed-up as part of the criteria to establish benignity.
Bias is also introduced as nodules are not randomly selected
for FNA in a multinodular gland but selected by size or
atypical ultrasound features. Having said this, 10 % of the
cases in our sample were malignant and comparable with an
overall incidence of 9.2–13% in patients with thyroid nodules
selected for FNA [1]. Even though our sample size is smaller
than the few other prospective studies [7, 9, 15] evaluating
thyroid ultrasound characteristics with colour Doppler, it is the
largest prospective study to date investigating the use of a set
of ultrasound and colour Doppler criteria in selecting malig-
nancy nodules for FNA or biopsy. As with many studies in the
literature evaluating thyroid ultrasound characteristics, the
diagnosis of a benign nodule in the majority of our patients
is a cytological rather than a histological one, as these patients
do not routinely undergo surgery for benign non-neoplastic
nodules. We hope to offset the limitations of cytological
diagnosis by performing FNA under ultrasound guidance by
an experienced radiologist rather than blindly [16, 17] and
with slides read by dedicated head and neck cytologists. By
additionally following-up these nodules for 6 months or more
to ensure stability in size [4], we hope to support the benign
nature of these nodules. None of the Thy 2 nodules in our
study were later classified as neoplastic on follow-up. How-
ever, we note from the observation of Ito et al. [18] that
papillary microcarcinomas may not increase in size over 1-
or 2-year follow-up. It may be worthwhile to note that if the
study was performed in a dedicated head and neck ultrasound
clinic (ultrasound being an operator-dependent procedure),
the results may not be replicated by observers in a general
clinic. Finally, our study uses the same dataset to determine the
set of ultrasound selection criteria for detecting malignancy
nodules as well as its accuracy. This requires validation by an
independent dataset, preferably in the form of a larger multi-
centre study.
Conclusion
Given the limitations of our study, it adds to the growing
body of evidence purporting the use of ultrasound and
colour Doppler as a safe, reproducible and pragmatic ap-
proach for investigating thyroid nodules for the presence of
malignancy and reducing unnecessary FNA biopsies.
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